Back to top
Send SMS Send Inquiry
Home » Products » Pharma Tablets » cefuroxime 500 mg + potassium clavunate 125 mg tab

cefuroxime 500 mg + potassium clavunate 125 mg tab

cefuroxime 500 mg + potassium clavunate 125 mg tab
cefuroxime 500 mg + potassium clavunate 125 mg tab
Send Inquiry
Product Code : LONCEF -CV
Brand Name : LONCEF -CV
Price And Quantity
  • Minimum Order Quantity
  • 500
  • Unit of Measure
  • Box/Boxes
  • Price
  • 1 INR
  • Price Range
  • 1.00 - 1.00 INR
Product Specifications
  • Drug Type
  • Other Types
  • Ingredients
  • Cefuroxime Axetil 500 mg + clavulanate potassium 125 mg
  • Physical Form
  • Tablets
  • Function
  • Antibiotic Medicine
  • Recommended For
  • ALL AGE
  • Dosage Guidelines
  • As directed by the physician
  • Quantity
  • 500 Boxes
  • Storage Instructions
  • store in a cool & dry ,dark plase
Product Description

efuroxime 500mg + Clavulanic acid 125mg Salt Information :

Uses of Cefuroxime 500mg + Clavulanic acid 125mg:

Cefuroxime is a cephalosporin antibiotic. Cefuroxime is used in the treatment of various bacterial infections. Cefuroxime is used in infections of respiratory tract infections like pharyngitis, otitis media, sinusitis, and bronchitis.

Side Effects of Cefuroxime 500mg + Clavulanic acid 125mg:

Large doses can cause cerebral irritation and convulsions; nausea, vomiting, diarrhoea, GI disturbances; erythema multiforme, Stevens-Johnson syndrome, epidermal necrolysis.Potentially Fatal: Anaphylaxis, nephrotoxicity, pseudomembranous colitis.

Drug Interactions of Cefuroxime 500mg + Clavulanic acid 125mg:

Probenecid decreases renal clearance of cefuroxime.Potentially Fatal: Nephrotoxicity with aminoglycosides and furosemide.

Contraindications of Cefuroxime 500mg + Clavulanic acid 125mg:

Hypersensitivity to cephalosporins.

Mechanism of Action of Cefuroxime 500mg + Clavulanic acid 125mg:

Cefuroxime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.Absorption: Absorbed from the GI tract with peak plasma concentrations after 2-3 hr (oral); may be enhanced by the presence of food.Distribution: Pleural and synovial fluid, sputum, bone and aqueous fluids; CSF (therapeutic concentrations). Crosses the placenta and enters breast milk. Protein-binding: Up to 50%.Metabolism: Rapidly hydrolysed (intestinal mucosa and blood).Excretion: Via the urine by glomerular filtration and renal tubular secretion (as unchanged); via bile (small amounts); 70 min (elimination half-life); prolonged in neonates and renal impairment.

Trade Information
  • Payment Terms
  • Cash on Delivery (COD), Cash Against Delivery (CAD)
  • Supply Ability
  • as per market demands Per Day Per Year
  • Delivery Time
  • 45 Days
  • Sample Policy
  • Within a certain price range free samples are available
  • Packaging Details
  • 1*6 , 1*10
  • Main Domestic Market
  • All India
  • Certifications
  • Drug Licence, WHO GMP Certified,

MEDILON HEALTHCARE
X


MEDILON HEALTHCARE
"A Pharmaceutical Manufacturing Company"
C&F (nickon Pharma) 1a-Second Floor, Dawa Bazar, Indore - 452001, Madhya Pradesh, India
Phone :+918068344891
Mr Krishan Yadav (Manager)
Mobile :+918068344891

Product Showcase
Administration Office:
H.No-561, Near Qila, Manimajra, Chandigarh -160101

Registered Office:
A-493, Rajni Vihar Colony, Heerapura, Jaipur-302024, Rajasthan